BRIGHTSPRING HEALTH SERVICES ($BTSG) is expected to release its quarterly earnings data on Monday, January 19th before market open, per Finnhub. Analysts are expecting revenue of $3,449,866,735 and earnings of $0.36 per share.
You can see Quiver Quantitative's $BTSG stock page to track data on insider trading, hedge fund activity, congressional trading, and more.
BRIGHTSPRING HEALTH SERVICES Insider Trading Activity
BRIGHTSPRING HEALTH SERVICES insiders have traded $BTSG stock on the open market 4 times in the past 6 months. Of those trades, 0 have been purchases and 4 have been sales.
Here’s a breakdown of recent trading of $BTSG stock by insiders over the last 6 months:
- GROUP PARTNERSHIP L.P. KKR sold 14,745,000 shares for an estimated $424,390,590
- PHOENIX AGGREGATOR L.P. KKR sold 14,745,000 shares for an estimated $424,390,590
- JON B ROUSSEAU (See Remarks) sold 235,000 shares for an estimated $6,763,770
- LISA A NALLEY (See Remarks) sold 20,000 shares for an estimated $575,640
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
BRIGHTSPRING HEALTH SERVICES Revenue
BRIGHTSPRING HEALTH SERVICES had revenues of $3.3B in Q3 2025. This is an increase of 28.17% from the same period in the prior year.
You can track BTSG financials on Quiver Quantitative's BTSG stock page.
BRIGHTSPRING HEALTH SERVICES Hedge Fund Activity
We have seen 152 institutional investors add shares of BRIGHTSPRING HEALTH SERVICES stock to their portfolio, and 97 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- PRICE T ROWE ASSOCIATES INC /MD/ added 7,059,722 shares (+226.0%) to their portfolio in Q3 2025, for an estimated $208,685,382
- MANUFACTURERS LIFE INSURANCE COMPANY, THE added 2,232,679 shares (+98.1%) to their portfolio in Q3 2025, for an estimated $65,997,991
- CITADEL ADVISORS LLC removed 2,225,191 shares (-89.8%) from their portfolio in Q3 2025, for an estimated $65,776,645
- 8 KNOTS MANAGEMENT, LLC added 1,733,548 shares (+inf%) to their portfolio in Q3 2025, for an estimated $51,243,678
- MILLENNIUM MANAGEMENT LLC removed 1,613,554 shares (-75.7%) from their portfolio in Q3 2025, for an estimated $47,696,656
- JANE STREET GROUP, LLC removed 1,599,202 shares (-77.0%) from their portfolio in Q3 2025, for an estimated $47,272,411
- POINT72 ASSET MANAGEMENT, L.P. removed 1,311,160 shares (-74.3%) from their portfolio in Q3 2025, for an estimated $38,757,889
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
BRIGHTSPRING HEALTH SERVICES Analyst Ratings
Wall Street analysts have issued reports on $BTSG in the last several months. We have seen 9 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Wells Fargo issued a "Overweight" rating on 01/07/2026
- BTIG issued a "Buy" rating on 12/23/2025
- Stephens & Co. issued a "Overweight" rating on 12/11/2025
- William Blair issued a "Outperform" rating on 12/08/2025
- BMO Capital issued a "Outperform" rating on 11/13/2025
- Mizuho issued a "Outperform" rating on 10/17/2025
- Morgan Stanley issued a "Overweight" rating on 10/14/2025
To track analyst ratings and price targets for BRIGHTSPRING HEALTH SERVICES, check out Quiver Quantitative's $BTSG forecast page.
BRIGHTSPRING HEALTH SERVICES Price Targets
Multiple analysts have issued price targets for $BTSG recently. We have seen 9 analysts offer price targets for $BTSG in the last 6 months, with a median target of $42.0.
Here are some recent targets:
- Stephen Baxter from Wells Fargo set a target price of $43.0 on 01/07/2026
- David Larsen from BTIG set a target price of $50.0 on 12/23/2025
- Ann Hynes from Mizuho set a target price of $42.0 on 12/18/2025
- Matthew Gillmor from Keybanc set a target price of $45.0 on 12/12/2025
- Dean Sublett from Stephens & Co. set a target price of $44.0 on 12/11/2025
- Joanna Gajuk from B of A Securities set a target price of $41.0 on 12/09/2025
- Sean Dodge from BMO Capital set a target price of $40.0 on 11/13/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
